BIRC3 and B-cell chronic lymphocytic leukemia: Recently, an enrichment in SF3B1, MGA, BIRC3, NFKBIE, CARD11 and XPO1 point mutations was noted in CLL samples with an acquired ibrutinib resistance [88,90].